📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
AksharChem India Credit Rating Outlook Revised to Negative; Long-term Rating Reaffirmed at CARE A-
CARE Ratings has reaffirmed AksharChem's long-term rating at 'CARE A-' but revised the outlook to 'Negative' due to sustained weak financial performance. The company reported a net loss of ₹5.24 crore in 9MFY26, with operating margins dropping to 4.43% from 7.39% YoY. Debt coverage metrics have deteriorated significantly, with Total Debt/PBILDT rising to 8.46x, though overall gearing remains comfortable at 0.25x. Recovery depends on the stabilization of the new PPT silica plant and mitigation of the 50% US export tariff impact.
Key Highlights
Outlook revised to Negative from Stable; Long-term rating reaffirmed at CARE A-.
Reported a net loss of ₹5.24 crore in 9MFY26 compared to a profit of ₹3.33 crore in 9MFY25.
Operating margins compressed to 4.43% in 9MFY26 due to 50% US export tariffs and high input costs.
Total Debt/PBILDT ratio weakened significantly to 8.46x in 9MFY26 from 2.69x in FY25.
PPT silica segment yet to achieve break-even, impacting overall overhead absorption and profitability.
💼 Action for Investors
Investors should exercise caution as the negative outlook indicates a risk of a future rating downgrade if margins remain suppressed. Monitor the silica segment's utilization and potential reduction in US tariffs as primary indicators for a turnaround.
Akshar Spintex Q3 FY26: Revenue Rises 32% YoY but Net Loss Widens to ₹3.8 Crore
Akshar Spintex reported a 32% year-on-year increase in revenue from operations to ₹34.35 crore for the quarter ended December 31, 2025. However, the company's net loss widened significantly to ₹3.80 crore compared to a loss of ₹2.33 crore in the same quarter last year, primarily due to higher raw material and purchase costs. For the nine-month period, the net loss has more than doubled to ₹7.00 crore. Critically, the statutory auditors highlighted significant internal control weaknesses, noting that the company failed to inspect fixed assets or inventories during the period.
Key Highlights
Revenue from operations grew 32.2% YoY to ₹3,435.12 lakhs in Q3 FY26.
Net loss widened to ₹379.50 lakhs from ₹233.35 lakhs in the year-ago period.
Total expenses surged to ₹4,134.39 lakhs, exceeding total income of ₹3,597.28 lakhs.
Auditors issued a disclaimer regarding the inability to verify the existence and condition of fixed assets and inventories.
Nine-month net loss stands at ₹699.97 lakhs compared to ₹330.55 lakhs in the previous year.
💼 Action for Investors
Investors should exercise extreme caution as widening losses are compounded by serious auditor concerns regarding the lack of fixed asset registers and inventory verification. Avoid fresh positions until internal controls and profitability show clear signs of improvement.
Akshar Spintex Q3 FY26: Net Loss Widens to ₹3.80 Cr; Auditor Raises Asset & Inventory Concerns
Akshar Spintex reported a widening net loss of ₹3.80 crore for the quarter ended December 31, 2025, compared to a loss of ₹2.33 crore in the same period last year. Although revenue from operations grew 32% YoY to ₹34.35 crore, total expenses surged to ₹41.34 crore, leading to operational losses. A significant concern was raised by the statutory auditors, who noted that the company has not maintained a fixed asset register or conducted physical inspections of its assets and inventories. For the nine-month period, the net loss has more than doubled to ₹7.00 crore from ₹3.31 crore in the previous year.
Key Highlights
Revenue from operations increased 32.2% YoY to ₹34.35 crore in Q3 FY26.
Net loss widened to ₹3.80 crore in Q3 FY26 from a loss of ₹2.33 crore in Q3 FY25.
Total expenses for the quarter stood at ₹41.34 crore, significantly exceeding total income of ₹35.97 crore.
Statutory auditors flagged the absence of a fixed asset register and lack of physical inventory verification.
9M FY26 net loss reached ₹7.00 crore, a sharp increase from the ₹3.31 crore loss in 9M FY25.
💼 Action for Investors
Investors should exercise extreme caution as the company is facing both deteriorating financial health and serious internal control lapses regarding asset and inventory verification. The auditor's inability to verify physical assets is a major governance red flag.
Akshar Spintex Q3 FY26: Revenue Rises to ₹34.35 Cr, Net Loss Widens to ₹3.80 Cr
Akshar Spintex reported a 32% YoY increase in revenue from operations to ₹3,435.12 lakhs for the quarter ended December 31, 2025. Despite the revenue growth, the company's net loss widened to ₹379.50 lakhs from a loss of ₹233.35 lakhs in the same period last year. Total expenses surged to ₹4,134.39 lakhs, significantly outpacing total income. A major concern for investors is the auditor's note regarding the lack of fixed asset registers and physical inventory verification during the period.
Key Highlights
Revenue from operations grew 32.2% YoY to ₹3,435.12 lakhs from ₹2,597.41 lakhs.
Net loss widened significantly to ₹379.50 lakhs in Q3 FY26 compared to a loss of ₹233.35 lakhs in Q3 FY25.
Total expenses rose to ₹4,134.39 lakhs, driven by higher raw material costs and purchases of stock-in-trade.
Auditors highlighted that the company failed to maintain a fixed asset register or conduct physical inventory inspections.
Earnings Per Share (EPS) declined to ₹(0.05) for the quarter from ₹(0.03) in the previous year.
💼 Action for Investors
Investors should exercise extreme caution as the company is reporting widening losses despite higher revenues. The auditor's inability to verify fixed assets and inventory points to significant internal control and governance risks.
AksharChem Credit Outlook Revised to Negative by CARE Ratings; Ratings Reaffirmed at 'A-'
CARE Ratings has reaffirmed AksharChem India's long-term rating at 'CARE A-' but revised the outlook from 'Stable' to 'Negative'. This revision follows a sharp decline in operating margins to 4.43% in 9MFY26 and a net loss of ₹5.24 crore compared to a profit in the previous year. The company's debt coverage metrics have also weakened significantly, with Total Debt to PBILDT rising to 8.46x. Investors should note the impact of a 50% US tariff on exports and the ongoing stabilization risks of the new PPT silica plant.
Key Highlights
Outlook revised to 'Negative' from 'Stable' for long-term facilities totaling ₹108.41 crore.
Operating margin compressed by 296 bps to 4.43% in 9MFY26 due to weak realisations and US tariffs.
Reported a net loss of ₹5.24 crore in 9MFY26 against a profit of ₹3.33 crore in 9MFY25.
Total Debt to PBILDT ratio deteriorated sharply to 8.46x in 9MFY26 from 2.69x in FY25.
Overall gearing remains comfortable at 0.25x as of March 31, 2025, despite recent performance pressure.
💼 Action for Investors
Investors should exercise caution as the negative outlook reflects sustained pressure on profitability and debt serviceability. Monitor the stabilization of the PPT silica segment and any relief in US export tariffs as key triggers for a potential recovery.
AksharChem Q3 Results: Revenue Drops 11% YoY, Reports Net Loss of ₹4.62 Cr
AksharChem India reported a weak set of numbers for Q3 FY26, with revenue from operations declining 11.4% YoY to ₹80.38 crore. The company swung to a net loss of ₹4.62 crore for the quarter, compared to a profit of ₹1.19 crore in the same period last year. Total expenses at ₹83.49 crore exceeded total income, primarily driven by higher material costs. A positive development is the commissioning of a 5.19 MWp solar power plant in November 2025, which is expected to reduce captive power costs going forward.
Key Highlights
Revenue from operations fell 11.4% YoY to ₹80.38 crore from ₹90.69 crore.
Reported a net loss of ₹4.62 crore in Q3 FY26 versus a net profit of ₹1.19 crore in Q3 FY25.
Cost of materials consumed rose to ₹54.74 crore from ₹44.78 crore in the preceding quarter.
Commissioned a 5.19 MWp solar power plant on November 12, 2025, for captive consumption.
Earnings Per Share (EPS) declined to negative ₹5.75 from ₹1.48 YoY.
💼 Action for Investors
Investors should remain cautious as the company has turned loss-making due to margin pressure and declining sales. Monitor the impact of the new solar plant on operating margins in the coming quarters to see if cost efficiencies materialize.
AksharChem Q3 FY26 Revenue Falls 11% YoY to ₹80.38 Cr; Swings to Net Loss of ₹4.62 Cr
AksharChem India reported a weak performance for Q3 FY26, with revenue from operations declining 11.4% YoY to ₹80.38 crore. The company posted a net loss of ₹4.62 crore, a significant downturn from the ₹1.19 crore profit recorded in the same quarter last year. Operational efficiency was pressured as total expenses of ₹83.49 crore exceeded total income, leading to a loss before tax of ₹3.07 crore. A potential positive for future quarters is the commissioning of a 5.19 MWp solar power plant in November 2025 for captive consumption.
Key Highlights
Revenue from operations decreased to ₹80.38 crore in Q3 FY26 from ₹90.69 crore in Q3 FY25.
Reported a net loss of ₹4.62 crore for the quarter compared to a net profit of ₹1.19 crore YoY.
Total expenses stood at ₹83.49 crore, resulting in an operational loss as revenue failed to cover costs.
EPS for the quarter turned negative at ₹(5.75) versus ₹1.48 in the previous year's corresponding quarter.
Successfully commissioned a 5.19 MWp ground-mounted solar power plant on November 12, 2025, for captive use.
💼 Action for Investors
Investors should exercise caution as the company has entered a loss-making phase with declining revenues. Monitor the next two quarters to see if the new solar plant effectively reduces power costs and improves operational margins.
Akshar Spintex Seeks Approval for Director Appointments and Remuneration Despite Losses
Akshar Spintex Limited has issued a postal ballot notice to ratify the appointment of Bhavin Jayantibhai Kothiya as an Independent Director for a five-year term. Notably, the company is re-seeking approval for Harry Paghdar as an Executive Director after shareholders previously rejected his appointment as Managing Director in August 2025. The company is also proposing a remuneration of ₹12 lakh per annum for Mr. Paghdar, which is being sought as minimum remuneration due to losses or inadequate profits in FY 2024-25. The e-voting period for these resolutions is scheduled from January 20 to February 18, 2026.
Key Highlights
Proposed appointment of Bhavin Jayantibhai Kothiya as Independent Director for a 5-year term ending November 2030.
Re-seeking approval for Harry Paghdar as Executive Director following a prior shareholder rejection in August 2025.
Proposed remuneration for Harry Paghdar is ₹1,00,000 per month, totaling ₹12,00,000 per annum.
Remuneration is sought as 'minimum remuneration' under Section 197 due to company losses in FY 2024-25.
E-voting period for shareholders is set from January 20, 2026, to February 18, 2026.
💼 Action for Investors
Investors should scrutinize the reasons for the previous shareholder rejection of Harry Paghdar and evaluate if the proposed remuneration is appropriate given the company's recent financial losses. Monitor the voting results as they will reflect shareholder confidence in the current management's governance.
Akshar Spintex Seeks Approval for Director Appointments and ₹12 Lakh Executive Remuneration
Akshar Spintex has issued a postal ballot notice to ratify the appointment of Mr. Bhavin Jayantibhai Kothiya as an Independent Director for a five-year term. Notably, the company is re-seeking approval for Mr. Harry Paghdar as an Executive Director after his previous appointment as Managing Director was rejected by shareholders in August 2025. The company is also requesting approval for Mr. Paghdar's remuneration of ₹12 lakh per annum, which will be treated as minimum pay despite the company incurring losses in FY 2024-25. The e-voting period for these resolutions is scheduled from January 20 to February 18, 2026.
Key Highlights
Ratification of Mr. Bhavin Jayantibhai Kothiya as Independent Director for a 5-year term until November 2030.
Re-seeking approval for Mr. Harry Paghdar as Executive Director following a prior shareholder rejection in August 2025.
Proposed annual remuneration of ₹12 lakh for Mr. Harry Paghdar despite the company reporting losses in FY 2024-25.
Remote e-voting window set for January 20, 2026, through February 18, 2026.
💼 Action for Investors
Investors should carefully evaluate the governance implications of re-proposing a director previously rejected by shareholders and the impact of executive remuneration on a loss-making entity. Monitor the voting results to assess shareholder confidence in the current management's decisions.
Akshar Spintex Seeks Approval for Director Appointments and ₹12 Lakh Executive Remuneration
Akshar Spintex Limited has initiated a postal ballot to seek shareholder approval for key management positions and remuneration. The company is proposing the ratification of Mr. Bhavin Jayantibhai Kothiya as an Independent Director for a five-year term. Notably, it is re-seeking approval for Mr. Harry Paghadar as an Executive Director after shareholders previously rejected his appointment as Managing Director in August 2025. Despite reporting losses or inadequate profits for FY 2024-25, the board has proposed a minimum remuneration of ₹12 lakh per annum for Mr. Paghadar.
Key Highlights
Proposed appointment of Mr. Harry Paghadar as Executive Director for a 5-year term from 2026 to 2031.
Proposed annual remuneration of ₹12,00,000 for Mr. Paghadar despite company losses in FY 2024-25.
Ratification of Mr. Bhavin Jayantibhai Kothiya as Independent Director for a term ending November 2030.
Remote e-voting period scheduled from January 20, 2026, to February 18, 2026.
The move follows a prior shareholder rejection of Mr. Paghadar's Managing Director appointment in August 2025.
💼 Action for Investors
Investors should scrutinize the justification for re-appointing a director previously rejected by shareholders and the impact of fixed executive pay on a loss-making company. Monitor the voting results on February 20, 2026, to assess institutional and retail shareholder confidence in the board.
AksharChem Commissions 5.19 MWp Ground Mounted Solar Plant for Captive Use
AksharChem India Limited has successfully commissioned a 5.19 MWp (DC) / 3.85 MWp (AC) ground-mounted solar power plant in Banaskantha, Gujarat. The facility is designed for captive consumption at the company's manufacturing unit located in Indrad (Chhatral). Power generation officially commenced on November 12, 2025, following certification from the Gujarat Energy Development Agency (GEDA). This initiative is part of the company's strategy to enhance its renewable energy portfolio and reduce long-term energy costs.
Key Highlights
Commissioned 5.19 MWp (DC) / 3.85 MWp (AC) solar power plant for captive consumption
Solar power generation started effective from November 12, 2025
Plant located at Village Makdala, Banaskantha to power the Indrad (Chhatral) factory
Received official commissioning certificate from GEDA on December 18, 2025
Move aimed at enhancing sustainability and reducing operational power costs
💼 Action for Investors
Investors should view this as a positive step toward margin improvement through reduced power costs. Monitor upcoming quarterly results to quantify the impact of lower energy expenses on the bottom line.